Using Multimodal MRI to Study Diabetic Kidney Disease
Studies MRI scans to examine kidney changes in adults with diabetic kidney disease.
Plain-language title generated from the registry record
Registry title: Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
Key facts
- Where
- Shenyang, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06452862, who can take part
Where in China
- Shengjing HospitalShenyang, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shengjing Hospital
- Trial code
- NCT06452862
- Record updated
- 13 April 2026
- Original description
The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.Read full original descriptionShow less
the Value of Multimodal Magnetic Resonance Imaging in the Diagnosis and Treatment Monitoring of Diabetic Kidney Disease
The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.
Inclusion: Clinically diagnosed diabetic kidney disease (DKD); Age 18-80 years.
Exclusion: Malignant tumor, active infection, or life expectancy <1 year; MRE contraindications (metal implants, claustrophobia, severe arrhythmia) or poor image quality; Other primary kidney diseases or systemic diseases affecting renal function; eGFR <15 mL/min/1.73m² or receiving renal replacement therapy; Pregnancy or lactation.